PT  - JOURNAL ARTICLE
AU  - Miyazaki, I
AU  - Cheung, R K
AU  - Gaedigk, R
AU  - Hui, M F
AU  - Van der Meulen, J
AU  - Rajotte, R V
AU  - Dosch, H M
TI  - T cell activation and anergy to islet cell antigen in type I diabetes.
DP  - 1995 Feb 01
TA  - The Journal of Immunology
PG  - 1461--1469
VI  - 154
IP  - 3
4099  - http://www.jimmunol.org/content/154/3/1461.short
4100  - http://www.jimmunol.org/content/154/3/1461.full
SO  - J. Immunol.1995 Feb 01; 154
AB  - Early exposure to cow milk proteins was linked to the development of type I diabetes by consistent epidemiology, and by feeding and tolerization studies in diabetes-prone rodents. Dietary BSA was suggested as the culprit because patients and relevant rodents have elevated anti-BSA Abs that precipitate the recently cloned protein, p69, from beta cell lysates. A total of 68 of 78 children with recent onset diabetes had BSA-reactive T cells at the time of diagnosis. Here we 1) map the fine specificity of these T cells, 2) delineate a homologous peptide sequence near the N-terminus of p69, and 3) demonstrate T cell recognition of this p69 sequence (T cell epitope p69, Tep69) by patient T cells. The Tep69 sequence is conserved in p69 of patients and diabetes-prone rodents. Whereas BSA triggers T cell proliferation, recombinant p69 and a synthetic Tep69 peptide induce early stages of T cell activation (IL-2R transcription) but insufficient IL-2 production and thus anergy. Exogenous IL-2 overrides anergy and allows proliferative expansion of p69-responsive T cells. In mixing experiments, p69 and Tep69 peptide prevented proliferative responses to BSA even at 100-fold smaller concentrations. These findings imply that high-affinity self-peptide triggers anergy, whereas low-affinity mimicry Ag triggers proliferative expansion of these T cells. This implies a disease model in which mimicry Ag would rescue autoreactive cells from ablation by self-Ag.